Lv2
104 积分 2026-08-26 加入
MK-4002, a B-cell maturation antigen-targeting T-cell engager, in relapsed or refractory multiple myeloma: a first-in-human, open-label, phase 1 study
16小时前
已关闭
Exploring the immunological effects of antibody–drug conjugates
2天前
已完结
A novel scaling approach for human pharmacokinetic prediction of antibody-drug conjugates using minimal nonclinical data: Integration of monkey PK and in vitro data
2天前
已完结
Preclinical Characterization of ADCT-241, an Exatecan-Based Antibody–Drug Conjugate Against PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer
2天前
已关闭
BCMA ‐Targeted Immunotherapy in Early Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Practical Management
2天前
已完结
MH-Penile-002: a phase II, prospective, single-arm trial of neoadjuvant anti-EGFR antibody-drug conjugate plus PD-1 inhibitor in penile cancer with challenging penile preservation or regional lymph node metastasis
17天前
已完结
Homocamptothecin Payloads with Enhanced Potency for Antibody-Drug Conjugates
23天前
已完结
Development of a novel humanized monoclonal antibody and efficacy profiling of site-directed antibody-drug conjugates for precision targeted therapy of CLDN18.2-positive cancers
1个月前
已完结
hIMB1636-LDM, a novel anti-TROP2 ADC, exerts potent antitumor efficacy in pancreatic cancer via direct cytotoxicity and immune activation
1个月前
已完结
TROP-2 in solid tumors: From oncogenic driver to therapeutic target with antibody-drug conjugates
1个月前
已完结
皖公网安备34019202002308
